Skip to main content
Year archive

BioInvent International — 2017 filings

All 28 regulatory filings released by BioInvent International (BINV) in 2017, sourced directly from the official regulator.

28 Filings
2017 Period
2017 filings (28)
Filing Released Lang
BioInvent and Transgene collaborate on next generation oncolytic viruses encoding an anti-CTLA-4 antibody to treat solid tumors
Regulatory Filings
2017-12-06 English
BioInvent och Transgene utvecklar ny behandling mot solida tumörer baserad på nästa generations onkolytiska virus och anti-CTLA-4-antikroppar
Regulatory Filings
2017-12-06 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report 9M 2017
2017-10-26 Swedish
Earnings Release 2017
Earnings Release 9M 2017
2017-10-26 English
The CEO of BioInvent Michael Oredsson will resign at the end of the year
Board/Management Information
2017-10-24 English
BioInvents VD Michael Oredsson avgår vid årsskiftet
Board/Management Information
2017-10-24 Swedish
Det japanska patentverket avser bevilja BioInvents viktiga patent relaterat till den immunonkologiska antikroppen BI-1206
Regulatory Filings
2017-09-12 Swedish
The Japanese patent office intends to grant BioInvent’s important patent relating to the immune-oncology antibody BI-1206
Regulatory Filings
2017-09-12 English
Interim / Quarterly Report 2017
Interim / Quarterly Report H2 2017
2017-07-26 Swedish
Earnings Release 2017
Earnings Release H1 2017
2017-07-26 English
BioInvent and ThromboGenics Amending Long-Standing Monoclonal Antibody Development Agreement
Capital/Financing Update
2017-07-10 English
BioInvent och ThromboGenics reviderar mångårigt avtal om utveckling av monoklonala antikroppar
Capital/Financing Update
2017-07-10 Swedish
Beslut på BioInvents årsstämma 2017
AGM Information
2017-05-17 Swedish
Resolutions at BioInvent’s Annual General Meeting 2017
AGM Information
2017-05-17 English
Interim / Quarterly Report 2017
Interim / Quarterly Report Q1 2017
2017-05-17 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q1 2017
2017-05-17 English
Europapatentverket avser bevilja BioInvent viktigt patent relaterat till den immunonkologiska antikroppen BI-1206
Regulatory Filings
2017-04-28 Swedish
European Patent Office intends to grant BioInvent core patent relating to its immune-oncology antibody BI-1206
Regulatory Filings
2017-04-28 English
Annual Report 2016
Annual Report FY 2016
2017-04-12 Swedish
Annual Report 2016
Annual Report FY 2016
2017-04-12 English
Annual General Meeting in BioInvent International AB
AGM Information
2017-04-12 English
Kallelse till årsstämma i BioInvent International AB
AGM Information
2017-04-12 Swedish
Earnings Release 2016
Earnings Release FY 2016
2017-02-15 Swedish
Earnings Release 2016
Earnings Release FY 2016
2017-02-15 English
Extraordinary General Meeting in BioInvent is cancelled
Regulatory Filings
2017-01-23 English
Inställd extra bolagsstämma i Bioinvent
Regulatory Filings
2017-01-23 Swedish
BioInvents samarbetspartner ThromboGenics startar fas II-studie med läkemedelskandidaten THR-317
Legal Proceedings Report
2017-01-10 Swedish
BioInvent’s collaboration partner ThromboGenics initiates Phase II study with the drug candidate THR-317
Regulatory Filings
2017-01-10 English